Literature DB >> 25190101

Dissemination of invasive aspergillosis: diagnostic and management dilemmas.

Roxana Elena Lazarescu1, Mark Vinelli2.   

Abstract

Invasive aspergillosis is a highly lethal opportunistic infection that poses a significant threat to immunocompromised patients. With studies suggesting that the incidence of this disease is increasing, and mortality rates remain high, early diagnosis and treatment are very important to improve patient survival. We present a case of a 63-year-old woman on an immunosuppression regimen with methylprednisolone and azathioprine for the treatment of autoimmune hepatitis, who presented with neurological and respiratory symptoms leading to a rapid clinical decline. A final diagnosis of disseminated invasive aspergillosis was made at autopsy. This case emphasises the importance in maintaining a high index of suspicion to ensure that the proper workup, diagnosis and treatment can be initiated earlier in the clinical presentation in an effort to decrease the extremely high mortality in these cases. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25190101      PMCID: PMC4158249          DOI: 10.1136/bcr-2014-204642

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

Review 1.  Detection and investigation of invasive mould disease.

Authors:  Manuel Cuenca-Estrella; Matteo Bassetti; Cornelia Lass-Flörl; Zdenek Rácil; Malcolm Richardson; Thomas R Rogers
Journal:  J Antimicrob Chemother       Date:  2011-01       Impact factor: 5.790

Review 2.  Diagnosing fungal infections in immunocompromised hosts.

Authors:  C M Tang; J Cohen
Journal:  J Clin Pathol       Date:  1992-01       Impact factor: 3.411

3.  Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Thomas J Walsh; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne van Burik; John R Wingard; Thomas F Patterson
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

Review 4.  Aspergillosis.

Authors:  Brahm H Segal
Journal:  N Engl J Med       Date:  2009-04-30       Impact factor: 91.245

Review 5.  Pulmonary aspergillosis: a clinical review.

Authors:  M Kousha; R Tadi; A O Soubani
Journal:  Eur Respir Rev       Date:  2011-09-01

Review 6.  Aspergillosis case-fatality rate: systematic review of the literature.

Authors:  S J Lin; J Schranz; S M Teutsch
Journal:  Clin Infect Dis       Date:  2001-01-26       Impact factor: 9.079

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.